In colon cancer, Deb et al6 conducted a retrospective study of 652 patients with colon cancer and found that Rad21 expression is related to disease progression, showing a positive correlation with chemotherapy in tumors harboring KRAS mutations and resistance. Here, KRAS is linked to malignant colon neoplasm.